Ouabain receptor binding of hydroxyprogesterone derivatives

Area of Science:

• Pharmacology
• Biochemistry
• Cardiovascular Science

Background:

• Cardiac glycosides, like ouabain, are crucial for heart function.
• Understanding their binding mechanisms is key to developing new cardiac therapies.
• A sensitive assay is needed to identify compounds interacting with cardiac glycoside receptors.

Purpose of the Study:

• To develop and validate a specific and sensitive radioreceptor assay for cardiac glycosides.
• To identify substances that can displace [3H]-ouabain from its binding sites in dog heart.
• To characterize the binding affinity of potential competing compounds.

Main Methods:

• A radioreceptor assay was established using high-affinity, saturable binding of [3H]-ouabain.
• The assay utilized the total particulate fraction isolated from dog heart.
• Displacement of [3H]-ouabain by various compounds was measured to determine IC50 values.

Main Results:

• Ouabain and other cardiac glycosides showed equipotent displacement of [3H]-ouabain (IC50s 10-30 nM).
• Specific hydroxyprogesterone derivatives, including chlormadinone acetate and cyproterone acetate, significantly competed (IC50s 2-21 microM).
• Prednisolone-3,20-bisguanyl-hydrazone exhibited moderate activity (IC50 6.4 microM), while most other tested substances were inactive.

Conclusions:

• A novel radioreceptor assay accurately measures cardiac glycoside binding in heart tissue.
• Certain hydroxyprogesterone derivatives demonstrate significant interaction with cardiac glycoside receptors.
• This assay provides a valuable tool for discovering novel compounds with potential cardiac effects.